SeaStar Medical Holding (ICU) Non-Current Assets (2021 - 2026)
SeaStar Medical Holding's (ICU) quarterly Non-Current Assets came in at $499000.0 in Q1 2026, down 93.27% YoY from $7.4 million in Q1 2025, and down 13.67% on a QoQ basis from $578000.0 in Q4 2025.
SeaStar Medical Holding (ICU) Non-Current Assets (2021 - 2026) Analysis & Trends
SeaStar Medical Holding (ICU) has 6 years of Non-Current Assets data on file, last reported at $499000.0 in Q1 2026.
- Quarterly Non-Current Assets fell 93.27% year-over-year to $499000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (down 76.32% YoY) and the FY2025 annual result came in at $578000.0, down 38.12% from the prior year.
- Non-Current Assets eased to $499000.0 in Q1 2026, from $578000.0 in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $7.4 million in Q1 2025 to a low of $499000.0 in Q1 2026.
- A 5-year average of $1.5 million and a median of $1.1 million in 2024 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets jumped 75850.0% — and 2026, when it tumbled 93.27%.
- Tracing ICU's Non-Current Assets over 5 years: stood at $1.5 million in 2022, then decreased by 20.67% to $1.2 million in 2023, then retreated by 22.49% to $934000.0 in 2024, then tumbled by 38.12% to $578000.0 in 2025, then retreated by 13.67% to $499000.0 in 2026.
- The last three Non-Current Assets figures came in at $499000.0 (Q1 2026), $578000.0 (Q4 2025), and $626000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.15 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.96 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 938.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 6.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 468.65 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 18.06 Bn |
| 10 | SeaStar Medical Holding | 13.68 Mn | 6.68 Mn | 561,000.00 | 421,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 421,000.00 |
| Mar 31, 2026 | 499,000.00 |
| Dec 31, 2025 | 578,000.00 |
| Sep 30, 2025 | 626,000.00 |
| Jun 30, 2025 | 753,000.00 |
| Mar 31, 2025 | 7.42 Mn |
| Dec 31, 2024 | 934,000.00 |
| Sep 30, 2024 | 970,000.00 |
| Jun 30, 2024 | 1.05 Mn |
| Mar 31, 2024 | 1.20 Mn |
| Dec 31, 2023 | 1.21 Mn |
| Sep 30, 2023 | 1.28 Mn |
| Jun 30, 2023 | 1.36 Mn |
| Mar 31, 2023 | 1.44 Mn |
| Dec 31, 2022 | 1.52 Mn |
| Dec 31, 2021 | 2,000.00 |
| Sep 30, 2021 | 105.58 Mn |
| Jun 30, 2021 | 105.58 Mn |
| Mar 31, 2021 | 105.57 Mn |